SCHEMBL17488783

SCHEMBL17488783

CNC1CCN(c2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)C1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 18/20 0.62
CDK6 Q00534 14/20 0.62
CDK2 P24941 12/20 0.62
CDK1 P06493 10/20 0.62
CCNB1 P14635 8/20 0.62
CCNE1 P24864 8/20 0.62
CDK9 P50750 4/20 0.62
CDK7 P50613 3/20 0.62
CCND3 P30281 3/20 0.62
EGFR P00533 2/20 0.62
CCNA2 P20248 2/20 0.62
CCND1 P24385 2/20 0.62
CDK5 Q00535 2/20 0.62
CCNT1 O60563 2/20 0.62
CIT O14578 1/20 0.62
GAK O14976 1/20 0.62
DYRK3 O43781 1/20 0.62
STK16 O75716 1/20 0.62
CCNK O75909 1/20 0.62
STK10 O94804 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17489156 1.00 CDK4 (0.62) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL25276066 0.96 CDK4 (0.63) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL17488768 0.94 CDK4 (0.62) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL30926572 0.89 CDK6 (0.71) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL17477176 0.89 CDK6 (0.71) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL17477153 0.89 CDK6 (0.71) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL17477154 0.89 CDK6 (0.71) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL17488736 0.89 CDK4 (0.58) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL17488701 0.89 CDK4 (0.64) CDK4CDK6CDK2CDK1CCNB1
SCHEMBL17488648 0.88 CDK4 (0.68) CDK4CDK6CDK2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed